With Pfizer, Moderna and Sputnik V shots being widely distributed since December, US pharma giant Merck and its partner Institut Pasteur in France have canceled their coronavirus vaccine projects due to low immune responses. Merck, known as MSD outside North America, said on Monday that it was discontinuing the development of two of its vaccine candidates. The decision was made after the results of Phase 1 clinical trials revealed that the immune responses produced by the candidates were inferior to those found in people who were cured from the coronavirus, as well as in rivaling vaccines. “We are grateful to our collaborators who work
Hence then, the article about out of the race us pharma giant merck french pasteur institute discontinue their covid 19 vaccine candidates was published today ( ) and is available onRussia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Out of the race: US pharma giant Merck & French Pasteur Institute discontinue their Covid-19 vaccine candidates )